Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of LZTFL1 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of LZTFL1 mRNA | affects expression | 17562736
|
C061133 |
Am 80 |
Am 80 results in increased expression of LZTFL1 mRNA | increases expression | 17229644
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of LZTFL1 mRNA | affects expression | 17331233
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LZTFL1 mRNA | decreases expression | 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of LZTFL1 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine results in decreased expression of LZTFL1 mRNA | decreases expression | 19363521
|
C014347 |
decitabine |
TP53 protein affects the reaction [decitabine results in decreased expression of LZTFL1 mRNA] | affects reaction|decreases expression | 19363521
|
C004925 |
methylmercuric chloride |
methylmercuric chloride results in decreased expression of LZTFL1 mRNA | decreases expression | 17961207
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of LZTFL1 mRNA | decreases expression | 17884332
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LZTFL1 mRNA | increases expression | 19465110
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methylmercuric chloride |
9.73 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.73 | 11752688 15322242 14514962 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.66 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.16 | 10982225 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Am 80 |
3.79 | 16819260 |
MESH:D050197 |
Atherosclerosis |
|
Am 80 |
4.45 | 16484594 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.25 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.07 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
2.90 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.90 | 3084413 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.64 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.69 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.95 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.95 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.95 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.06 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 15340226 12621046 8697196 16354765 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.36 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.28 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.42 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.42 | 11743745 19739265 12540782 17522070 12153990 12958197 18713872 16081117 2444490 15968718 10774834 14725611 18071297 16109766 16485898 16177239 14550746 11421492 19923254 16227642 17562736 19085960 19370779 14986274 12594235 11287661 16393943 10915739 11461765 15619225 10663392 16781746 19164858 17906064 19416960 12705907 11739529 11834606 11529661 12392966 19420014 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.42 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.42 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.58 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Am 80 |
5.33 | 16819260 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.43 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.06 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.36 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.36 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.99 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.50 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.62 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.43 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.71 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.15 | 12621046 15340226 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 15340226 16354765 8697196 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.86 | 16870215 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.17 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.17 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.33 | 17581917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.95 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.76 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.16 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.16 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.85 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.85 | 12371664 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.16 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.21 | 19117987 17236224 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.41 | 18206229 19010910 19387464 17679729 18704418 18460780 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.78 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Am 80 |
4.77 | 16531727 16819260 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.67 | 11587558 19014921 16610002 12969438 12587719 19784758 16611625 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.43 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.59 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.59 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.14 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.14 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.28 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.56 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.27 | 16505122 17785578 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.83 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.25 | 16166281 16966607 18303189 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.11 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
Am 80 |
8.38 | 17229644 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
8.38 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.49 | 19157545 16882708 19010910 18608210 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.15 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.80 | 19470736 17925555 19116145 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.47 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.45 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.04 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.62 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.70 | 19331143 19259094 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.56 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.83 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.15 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.40 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.48 | 11896295 11118676 11222880 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.99 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Am 80 |
4.66 | 16289102 |
MESH:D011565 |
Psoriasis |
|
Am 80 |
6.35 | 16819260 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
6.35 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.09 | 17365031 17975199 17322281 15814490 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.62 | 19155313 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.67 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.13 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.48 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.40 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.40 | 17616700 19087683 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.60 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.20 | 10982225 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.23 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.30 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.76 | 17120751 |